ACTH therapy on intractable epilepsy in Hemiconvulsion-Hemiplegia-Epilepsy syndrome

作者：Shimakawa Shuichi^*; Nomura Shohei; Ogino Motoko; Fukui Miho; Kashiwagi Mitsuru; Tanabe Takuya; Tamai Hiroshi

来源：Brain & Development, 2015, 37(7): 733-737.

DOI：10.1016/j.braindev.2014.11.003

• Hemiconvulsion-Hemiplegia-Epilepsy syndrome
• Adrenocorticotropic hormone therapy
• Lamotrigine
• Treatment

Introduction: In the chronic phase of Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome, developing epilepsy may be intractable. Herein, we report a case where adrenocorticotropic hormone (ACTH) ceased an intractable habitual partial seizure in a patient with HHE syndrome.
Case report: A developmentally normal one-year-old girl presented with left focal motor status epilepticus in the clinical course of rotavirus infection. She was diagnosed with HH syndrome. At 4 months after status epilepticus, she developed partial seizures that occurred daily, and which resulted in a stooped posture, head rotation to the right, and contraction of both upper limbs predominantly in the left arm. At this time, she was diagnosed with idiopathic HHE syndrome. Her seizures were not reduced by sodium valproate, clonazepam, clobazam, zonisamide, phenytoin, phenobarbital, topiramate, lamotrigine, or liposteroid. At the age of 7, ACTH therapy was performed. On the 10th day of ACTH therapy, the habitual seizure was ceased. However, partial seizures characterized by left arm contraction then developed. Treatment with 350 mg/day lamotrigine prevented this emerging seizure. She has been free of both seizure types for more than one year, with no serious adverse effects of ACTH therapy.
Conclusion: We suggest that ACTH therapy may be useful for patients with HHE, although further studies are required.

• 出版日期2015-8